Patients were randomized to receive active treatment or placebo using a rotation method utilizing the abdomen and upper arms/shoulders for 182 days. All patients were started at a daily dose of mg (two pump actuations) AndroGel % or matching placebo on Day 1 of the study. Patients returned to the clinic on Day 14, Day 28, and Day 42 for predose serum total testosterone assessments. The patient's daily dose was titrated up or down in mg increments if the predose serum testosterone value was outside the range of 350-750 ng/dL. The study included four active AndroGel % doses: mg, mg, mg, and 81 mg daily.